These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18756451)

  • 21. Caroli's disease and orthotopic liver transplantation.
    Habib S; Shakil O; Couto OF; Demetris AJ; Fung JJ; Marcos A; Chopra K
    Liver Transpl; 2006 Mar; 12(3):416-21. PubMed ID: 16498655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
    Walter T; Dumortier J; Guillaud O; Hervieu V; Scoazec JY; Boillot O
    Liver Transpl; 2007 Feb; 13(2):294-301. PubMed ID: 17256784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.
    Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone P; Bernardi M;
    J Clin Gastroenterol; 2010 Jan; 44(1):52-7. PubMed ID: 19581813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation.
    Shiffman ML; Contos MJ; Luketic VA; Sanyal AJ; Purdum PP; Mills AS; Fisher RA; Posner MP
    Transplantation; 1994 Feb; 57(4):526-32. PubMed ID: 8116036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post-transplant hepatitis C infection.
    Schmilovitz-Weiss H; Cohen M; Pappo O; Sulkes J; Braun M; Tur-Kaspa R; Ben-Ari Z
    Clin Transplant; 2007; 21(3):391-7. PubMed ID: 17488390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
    Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
    AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML; Stravitz RT; Contos MJ; Mills AS; Sterling RK; Luketic VA; Sanyal AJ; Cotterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Oct; 10(10):1248-55. PubMed ID: 15376308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The recurrence of hepatitic C in orthotopic liver transplantation].
    Germi MR; Pellicci R; Testa R; Ardizzone G; Lemut F; Pozzo A; Siani C
    Minerva Anestesiol; 1998; 64(1-2):29-33. PubMed ID: 9658788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
    Kuo A; Tan V; Lan B; Khalili M; Feng S; Roberts JP; Terrault NA
    Liver Transpl; 2008 Oct; 14(10):1491-7. PubMed ID: 18825708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo nonalcoholic fatty liver disease after liver transplantation.
    Seo S; Maganti K; Khehra M; Ramsamooj R; Tsodikov A; Bowlus C; McVicar J; Zern M; Torok N
    Liver Transpl; 2007 Jun; 13(6):844-7. PubMed ID: 17029282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review.
    De Martin E; Senzolo M; Gambato M; Germani G; Vitale A; Russo FR; Burra P
    Transplant Proc; 2010; 42(6):2223-5. PubMed ID: 20692449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C.
    Ciccorossi P; Maina AM; Oliveri F; Petruccelli S; Leandro G; Colombatto P; Moriconi F; Mosca F; Filipponi F; Bonino F; Brunetto MR
    Liver Int; 2007 Jun; 27(5):612-9. PubMed ID: 17498245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence.
    Ghabril M; Dickson RC; Krishna M; Machicao V; Aranda-Michel J; Bonatti H; Nguyen JH
    Liver Transpl; 2011 Jun; 17(6):685-94. PubMed ID: 21618689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The evolution of the hypervariable region-1 of hepatitis C virus may predict liver fibrosis outcome after renal transplantation].
    Kamar N; Rostaing L; Selves J; Sandres-Saune K; Alric L; Durand D; Izopet J
    Nephrol Ther; 2005 Dec; 1(6):345-54. PubMed ID: 16895705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.